NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Coverage Initiated at StockNews.com

StockNews.com started coverage on shares of NovaBay Pharmaceuticals (NYSEAMERICAN:NBY – Get Rating) in a research note released on Tuesday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. NovaBay Pharmaceuticals Stock Performance NYSEAMERICAN NBY opened at $0.68 on Tuesday. The company has a market capitalization of $1.27 million, a price-to-earnings ratio of […]

Related Keywords

,Renaissance Technologies ,Novabay Pharmaceuticals Inc ,Novabay Pharmaceuticals Stock Performance ,Novabay Pharmaceuticals ,Armistice Capital ,Virtu Financial ,Novabay Pharmaceuticals Company Profile ,News Ratings For Novabay Pharmaceuticals Daily ,Get Rating ,Bay Pharmaceuticals ,Altium Capital Management ,Novabay Pharmaceuticals Daily ,Nyseamerican Nby ,Anby ,Medical ,Initiated Coverage ,Stocknews Com ,